戻る Agenda
Session 4: Towards the Integration of Patient Preferences into Decision Making
Session Chair(s)
Bennett Levitan, MD, PhD
Executive Director, Benefit-Risk Assessment / Epidemiology
Johnson & Johnson, United States
Session 4: Towards the Integration of Patient Preferences into Decision Making
Speaker(s)
Applications of Patient Preference Studies in Regulatory Decisions
Michelle Tarver, MD, PhD
FDA, United States
Deputy Center Director for Transformation, CDRH
Applications of Patient Preference Studies in Regulatory Decisions
Francesco Pignatti, MD
European Medicines Agency, Netherlands
Scientific Adviser for Oncology
Applications of Patient Preference Studies in HTA Decisions
Ana Margarida Oliveira
Infarmed, Portugal
Pharmacist, Health Technology Assessment Department
Applications of Patient Preference Studies in HTA Decisions
Irina Cleemput, PhD
Belgian Health Care Knowledge Centre (KCE), Belgium
Scientific Programme Director
Applications of Patient Preference Studies in Industry Decisions
Brett Hauber, PhD, MA
Pfizer Inc, United States
Patient Preference Evidence Integration Lead